20 (AIDX) Preferred Shares (2024 - 2025)
20 (AIDX) reported Preferred Shares of $12040.0 for Q4 2025, up 1829.49% on a YoY basis from $624.0 in Q4 2024, and up 1829.49% quarter-over-quarter from $624.0 in Q4 2024.
20 (AIDX) Preferred Shares (2024 - 2025) Analysis & Trends
20 has reported Preferred Shares for 2 years, with the latest figure at $12040.0 in Q4 2025.
- For the quarter ending Q4 2025, Preferred Shares rose 1829.49% year-over-year to $12040.0; the trailing twelve-month figure through Dec 2025 stood at $12040.0 (up 1829.49% YoY), and the FY2025 full-year result was $12040.0, up 1829.49% from the prior year.
- Preferred Shares for Q4 2025 stood at $12040.0, up from $624.0 in the prior quarter.
- The five-year high for Preferred Shares was $12040.0 in Q4 2025, with the low at $624.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | 20 | - | - | 62,884.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,040.00 |
| Dec 31, 2024 | 624.00 |